Prevalence and clinical correlates of abnormal lipid metabolism in first-episode and drug-naive patients with major depressive disorder with abnormal glucose metabolism
文献类型:期刊论文
作者 | Zhu, Quanfeng1; Jiang, Guojun1; Lang, XiaoE2; Fu, Zhengchuang1; Zhang, Peng1; Zheng, Yali1; Zhang, Xiangyang3,4![]() |
刊名 | SCIENTIFIC REPORTS
![]() |
出版日期 | 2023-05-18 |
卷号 | 13期号:1页码:8 |
ISSN号 | 2045-2322 |
DOI | 10.1038/s41598-023-35290-6 |
通讯作者 | Zhang, Xiangyang(zhangxy@psych.ac.cn) |
英文摘要 | Comorbid glucose metabolism abnormalities are very common in patients with major depressive disorder (MDD), and glucose metabolism and lipid metabolism are closely related. However, there are few researches on the incidence and related factors of lipid metabolism abnormalities among MDD patients with comorbid glucose metabolism abnormalities. A cross-sectional study involving 1718 first-episode and drug-naive (FEDN) MDD patients was conducted. The 17-item Hamilton Depression Scale (HAMD-17), Hamilton Anxiety Rating Scale (HAMA) and Positive and Negative Syndrome Scale (PANSS) positive subscale were utilized to evaluate depressive, anxiety and psychotic symptom, respectively. Serum thyroid function-related parameters, glucose- and lipid-metabolism parameters were measured. The prevalence of abnormal lipid metabolism was significantly higher in FEDN MDD patients with abnormal glucose metabolism than in those without abnormal glucose metabolism (P < 0.001). In MDD patients with abnormal glucose metabolism, TSH, FT3 and body mass index (BMI) levels were significantly higher in the abnormal lipid metabolism subgroup than in the non-abnormal lipid metabolism subgroup. Binary logistic regression analysis showed that TSH, FT3 and BMI were the influencing factors of abnormal lipid metabolism in MDD patients with abnormal glucose metabolism (all P < 0.05). MDD patients with abnormal glucose metabolism have a high prevalence of abnormal lipid metabolism. Moreover, abnormal glucose metabolism was an independent risk factor for abnormal lipid metabolism in patients with MDD. In addition, thyroid hormone function and BMI may contribute to the co-occurrence of abnormal lipid metabolism in MDD patients with abnormal glucose metabolism. |
收录类别 | SCI |
WOS关键词 | ASSOCIATION ; CHOLESTEROL ; RECEPTOR |
WOS研究方向 | Science & Technology - Other Topics |
语种 | 英语 |
WOS记录号 | WOS:000992525500014 |
出版者 | NATURE PORTFOLIO |
源URL | [http://ir.psych.ac.cn/handle/311026/45416] ![]() |
专题 | 心理研究所_中国科学院心理健康重点实验室 |
通讯作者 | Zhang, Xiangyang |
作者单位 | 1.Hangzhou Normal Univ, Affiliated Xiaoshan Hosp, Hangzhou, Peoples R China 2.Shanxi Med Univ, Hosp 1, Clin Med Coll 1, Dept Psychiat, Taiyuan, Peoples R China 3.Inst Psychol, CAS Key Lab Mental Hlth, Beijing, Peoples R China 4.Univ Chinese Acad Sci, Dept Psychol, 16 Lincui Rd, Beijing 100101, Peoples R China |
推荐引用方式 GB/T 7714 | Zhu, Quanfeng,Jiang, Guojun,Lang, XiaoE,et al. Prevalence and clinical correlates of abnormal lipid metabolism in first-episode and drug-naive patients with major depressive disorder with abnormal glucose metabolism[J]. SCIENTIFIC REPORTS,2023,13(1):8. |
APA | Zhu, Quanfeng.,Jiang, Guojun.,Lang, XiaoE.,Fu, Zhengchuang.,Zhang, Peng.,...&Zhang, Xiangyang.(2023).Prevalence and clinical correlates of abnormal lipid metabolism in first-episode and drug-naive patients with major depressive disorder with abnormal glucose metabolism.SCIENTIFIC REPORTS,13(1),8. |
MLA | Zhu, Quanfeng,et al."Prevalence and clinical correlates of abnormal lipid metabolism in first-episode and drug-naive patients with major depressive disorder with abnormal glucose metabolism".SCIENTIFIC REPORTS 13.1(2023):8. |
入库方式: OAI收割
来源:心理研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。